Knight Therapeutics Inc.

2:45 PM - 3:00 PM (PDT), Tuesday, June 14, 2022
Knight is a multinational specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for Canada and Latin America
Ticker:
GUD
Exchange:
TSX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Quebec
Company HQ Country:
Canada
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
Multiple products
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Business Officer
Knight Therapeutics Inc.